Working… Menu
Trial record 21 of 124 for:    ZOLPIDEM AND Central Nervous System Depressants

Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02817750
Recruitment Status : Completed
First Posted : June 29, 2016
Last Update Posted : June 11, 2018
Information provided by (Responsible Party):
Biolab Sanus Farmaceutica

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 22, 2018
Actual Study Completion Date : February 22, 2018